Depression, Anxiety and Glucose Metabolism in the General Dutch Population: The New Hoorn Study
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
BACKGROUND: There is a well recognized association between depression and diabetes. However, there is little empirical data about the prevalence of depressive symptoms and anxiety among different groups of glucose metabolism in population based samples. The aim of this study was to determine whether the prevalence of increased levels of depression and anxiety is different between patients with type 2 diabetes and subjects with impaired glucose metabolism (IGM) and normal glucose metabolism (NGM). METHODOLOGY/PRINCIPAL FINDINGS: Cross-sectional data from a population-based cohort study of 2667 residents, 1261 men and 1406 women aged 40-65 years from the Hoorn region, the Netherlands. Depressive symptoms and anxiety were measured using the Centre for Epidemiologic Studies Depression Scale (CES-D, score >or=16) and the Hospital Anxiety and Depression Scale--Anxiety Subscale (HADS-A, score >or=8), respectively. Glucose metabolism status was determined by oral glucose tolerance test. In the total study population the prevalence of depressive symptoms and anxiety for the NGM, IGM and type 2 diabetes were 12.5, 12.2 and 21.0% (P = 0.004) and 15.0, 15.3 and 19.9% (p = 0.216), respectively. In men, the prevalence of depressive symptoms was 7.7, 9.5 and 19.6% (p<0.001), and in women 16.4, 15.8 and 22.6 (p = 0.318), for participants with NGM, IGM and type 2 diabetes, respectively. Anxiety was not associated with glucose metabolism when stratified for sex. Intergroup differences (NGM vs. IGM and IGM vs. type 2 diabetes) revealed that higher prevalences of depressive symptoms are mainly manifested in participants with type 2 diabetes, and not in participants with IGM. CONCLUSIONS: Depressive symptoms, but not anxiety are associated with glucose metabolism. This association is mainly determined by a higher prevalence of depressive symptoms in participants with type 2 diabetes and not in participants with IGM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The validity of the Hospital Anxiety and Depression Scale
Bjelland, I., Dahl, A. A., Haug, T. T., & Neckelmann, D. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(01)00296-3 · Cited by 9,779 · cited 1×
“The generally used cut-off score of 8 and above was used to identify respondents with the possible presence of anxiety [20].”
MethodSPINHOVEN, P., ORMEL, J., SLOEKERS, P. P. A., KEMPEN, G. I. J. M., SPECKENS, A. E. M., & HEMERT, A. M. V. (1997) · Psychological Medicine · doi:10.1017/s0033291796004382 · Cited by 2,158 · cited 1×
“Nowadays it is also used to indicate the presence of anxiety in general medical patients [19].”
BackgroundDepression and poor glycemic control: a meta-analytic review of the literature.
Lustman, P. J., Anderson, R. J., Freedland, K. E., de Groot, M., Carney, R. M., & Clouse, R. E. (2000) · Diabetes Care · doi:10.2337/diacare.23.7.934 · Cited by 1,854
Association of depression and diabetes complications: a meta-analysis
de Groot, M., Anderson, R., Freedland, K. E., Clouse, R. E., & Lustman, P. J. (2001) · Psychosomatic Medicine · doi:10.1097/00006842-200107000-00015 · Cited by 1,799 · cited 1×
“It is well-known that patients with depression and diabetes, compared with patients with diabetes alone, have been linked with poor self-care and adherence to medical treatment [3], poorer glycemic control [4], more diabetes complications [5], and increased health-care use and costs [6].”
BackgroundDepression and Type 2 Diabetes Over the Lifespan
Mezuk, B., Eaton, W. W., Albrecht, S., & Golden, S. H. (2008) · Diabetes Care · doi:10.2337/dc08-0985 · Cited by 1,558
Depression and Diabetes: Impact of Depressive Symptoms on Adherence, Function, and Costs
Ciechanowski, P. S., Katon, W. J., & Russo, J. E. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.21.3278 · Cited by 1,465 · cited 1×
“It is well-known that patients with depression and diabetes, compared with patients with diabetes alone, have been linked with poor self-care and adherence to medical treatment [3], poorer glycemic control [4], more diabetes complications [5], and increased health-care use and costs [6].”
BackgroundInflammation and Activated Innate Immunity in the Pathogenesis of Type 2 Diabetes
Pickup, J. C. (2004) · Diabetes Care · doi:10.2337/diacare.27.3.813 · Cited by 1,414 · cited 1×
“Alternative mechanisms include, for example, deregulation of the hypothalamic–pituitary–adrenal axis and the sympathetic nervous system [25], sex steroid hormone levels [26], low grade inflammation [27], or vitamin D deficiency [28].”
BackgroundDepression and Diabetes Treatment Nonadherence: A Meta-Analysis
Gonzalez, J. S., Peyrot, M., McCarl, L. A., Collins, E. M., Serpa, L., Mimiaga, M. J., & Safren, S. A. (2008) · Diabetes Care · doi:10.2337/dc08-1341 · Cited by 1,060 · cited 1×
“It is well-known that patients with depression and diabetes, compared with patients with diabetes alone, have been linked with poor self-care and adherence to medical treatment [3], poorer glycemic control [4], more diabetes complications [5], and increased health-care use and costs [6].”
BackgroundAnxiety and depression symptoms in patients with diabetes
Collins, M. M., Corcoran, P., & Perry, I. J. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02648.x · Cited by 465
The role of depression and anxiety in onset of diabetes in a large population-based study
Engum, A. (2007) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2006.07.009 · Cited by 330
Relationship Between A1C and Glucose Levels in the General Dutch Population
van 't Riet, E., Alssema, M., Rijkelijkhuizen, J. M., Kostense, P. J., Nijpels, G., & Dekker, J. M. (2010) · Diabetes Care · doi:10.2337/dc09-0677 · Cited by 199
Self-citationPenninx, B. W. J. H., Beekman, A. T. F., Corsi, A. M., Bremmer, M., Hoogendijk, W. J., Guralnik, J. M., Ferrucci, L., & Bandinelli, S. (2007) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e318033ed80 · Cited by 134
Cited by
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Association of diabetes with anxiety: a systematic review and meta-analysis
Smith, K. J., Béland, M., Clyde, M., Gariépy, G., Pagé, V., Badawi, G., Rabasa-Lhoret, R., & Schmitz, N. (2013) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2012.11.013 · Cited by 447
Khuwaja, A. K., Lalani, S., Dhanani, R., Azam, I. S., Rafique, G., & White, F. (2010) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-2-72 · Cited by 253
Sun, N., Lou, P., Shang, Y., Zhang, P., Wang, J., Chang, G., & Shi, C. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-012540 · Cited by 132
Anxiety and risk of type 2 diabetes: Evidence from the Baltimore Epidemiologic Catchment Area Study
Edwards, L. E., & Mezuk, B. (2012) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2012.09.018 · Cited by 52
Metadata
- Authors
- Bouwman, V., Adriaanse, M. C., van ’t Riet, E., Snoek, F. J., Dekker, J. M., & Nijpels, G.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-04-01
- Volume
- 5
- Issue
- 4
- Pages
- e9971
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2099039403
- Cited by
- 123
- References
- 12
- FWCI
- 6.16
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.